← Back to Search

Behavioural Intervention

AIRWISE Intervention for Cardiovascular Disease

N/A
Recruiting
Research Sponsored by University of Montana
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult of at least 20 years of age
Undergone a percutaneous coronary intervention (PCI) procedure at the Providence Heart Institute (PHI).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial is testing a program called AIRWISE to improve indoor air quality for patients who recently had heart procedures. The program includes air filtration, education, and behavior recommendations. All participants will receive the program

Who is the study for?
This trial is for adults over 20 who've had a recent heart procedure called percutaneous coronary intervention at the Providence Heart Institute. They must live in one place most of the week, have electricity, an email address, and internet or cell service to participate in surveys.
What is being tested?
The AIRWISE study tests an indoor air pollution intervention that includes air filtration systems, education, and behavior tips aimed at improving heart patients' health. All participants will try this approach to see if it's accepted and used effectively.
What are the potential side effects?
Since AIRWISE focuses on non-invasive methods like air quality improvement and education rather than medication or surgery, no direct medical side effects are expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 20 years old or older.
Select...
I had a heart procedure at Providence Heart Institute.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evaluate the implementation of an indoor air pollution intervention.
Secondary study objectives
Fine particulate matter (PM2.5)
Life's Essential 8

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Air pollution intervention implementationExperimental Treatment1 Intervention
AIRWISE intervention implementation

Find a Location

Who is running the clinical trial?

University of MontanaLead Sponsor
26 Previous Clinical Trials
3,308 Total Patients Enrolled
Providence Heart InstituteUNKNOWN
~3 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top